The latest myeloma news
Researchers discover genes that predict good response to blood cancer therapy
Mount Sinai researchers have for the first time identified genes that predict a good response…
Browsing: Myeloma
Multiple myeloma test detects more deadly forms of the disease
A test for the common blood cancer multiple myeloma also holds clear clues that the…
EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma
Chimeric antigen receptor (CAR) T cell therapy is a form of immunotherapy in which T…
ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple myeloma patients
The use of autologous stem cell transplant (ASCT) early in the course of treatment showed…
Achilles’ heel of high-risk multiple myeloma
Chromosomal abnormalities are found in most multiple myeloma (MM) patients. While myeloma patients have generally…
Why multiple myeloma returns
Multiple myeloma is a cancer which affects ‘plasma cells’, a type of immune cell found…
New treatment target for bone marrow cancer
Multiple myeloma is a cancer which affects ‘plasma cells’, a type of immune cell found…
A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma
Multiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor…
Identification of a novel therapeutic target in multiple myeloma
Multiple myeloma is a cancer caused by the abnormal proliferation of plasma cells, white blood…
Phase I/II study shows increased PFS for patients with r/r multiple myeloma who received ixazomib in combination with pomalidomide and dexamethasone
Early results from an Alliance for Clinical Trials in Oncology randomised clinical trial of adults…